Liver X receptor a (LXRa) and sterol regulatory element binding protein-1c (SREBP-1c) were studied in rats with nonalcoholic steatohepatitis (NASH) induced by a high-fat diet. Forty 5-week-old rats were fed either a high-fat diet (n = 30) or a normal diet (n = 10) for 9, 13 or 17 weeks. The mRNA and protein levels for LXRa and SREBP-1c were measured at each time point, as was fatty acid synthase (FAS) activity and the serum levels of free fatty acid (FFA) and triglyceride (TG). The mRNA and protein levels for LXRa and SREBP-1c, FAS activity and serum levels of FFA and TG all significantly increased from week 9 in the high-fat diet rats versus controls. In conclusion, a high-fat diet upregulates LXRa which, in turn, upregulates SREBP-1c, increasing the activity of FAS and FFA and accumulation of TG in hepatocytes. Thus, LXRa and SREBP-1c contribute to the development of NASH.
Introduction
Non-alcoholic fatty liver disease (NAFLD) is one of the most common hepatic disorders in China. 1 In most cases, it does not progress to more severe liver disease and is usually innocuous; however 20% of patients will develop non-alcoholic steatohepatitis (NASH) with inflammation, hepatocellular necrosis and excessive deposition of lipids. 2 One-fifth of these patients will then develop liver cirrhosis and chronic hepatic failure and will eventually need a liver transplant. 3 Hepatocellular carcinoma can also be a consequence of NAFLD. 4 A survey in 2005 showed that the prevalence of NASH in Shanghai, China was 15.35% 1 and, in the USA, it is 25%. 5 Although the exact mechanisms leading *Zheng-Lin Ai and Chao-Hui Zhu contributed equally to this work.
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to progression from NAFLD to NASH remain unknown, a large amount of information on the mechanisms of fat infiltration, damage, inflammation and fibrosis in NASH have been reported. 6, 7 The most widely accepted hypothesis to explain the progression from simple NAFLD to NASH is the 'two-hit hypothesis' 8 where pathogenesis is determined by the development of hepatic steatosis in conjunction with other factors, one of which is reactive oxygen species that may trigger steatohepatitis by lipid peroxidation, cytokine induction or induction of fas-ligand. 9 Accumulation of fat, mainly in the form of triglycerides, is the sine qua non for the development of NASH. The mechanism responsible for the increase in hepatic fat accumulation is unclear and little information is available on the time course of the development of hepatic steatosis. Animal models indicate that the liver might accumulate lipids within a few weeks and even a few days. 9 It has been suggested that fatty liver might result from increased delivery of fatty acids, impaired hepatic fatty acid oxidation and/or impaired synthesis or secretion of very low-density lipoprotein. 10 Among these factors, the increased flow of free fatty acids (FFAs) to the liver is considered the most important. 11 Lipid homeostasis in animal cells is regulated by a family of transcription factors, the sterol regulatory element binding proteins (SREBPs). 12 They are transcription factors that belong to the basic helix-loophelix-leucine zipper family. 13 Three SREBPs have been identified to date: SREBP-1a and SREBP-1c are produced from the same gene through the use of alternate promoters, and SREBP-2 is encoded by a separate gene. 14, 15 They activate the expression of genes involved in the synthesis and uptake of, among other things, cholesterol, fatty acids and phospholipids. 16, 17 
SREBP-1c
preferentially activates genes involved with FFA. 18 Previous reports on the regulation of SREBP-1c have all demonstrated that liver X receptor (LXR) α is a strong activator of the SREBP-1c gene promoter. The LXRs belong to a subgroup of nuclear receptors that are considered to be 'metabolic receptors'. 18 -20 The two LXRs, LXRα and LXRβ, are activated by oxysterols that play an important role in the control of lipid homeostasis. 21 LXRα has been implicated in the regulation of cholesterol and fatty acid metabolism in multiple tissues, including liver and intestine, as well as in macrophages. 22, 23 In liver tissue, LXRα is involved in lipogenesis by directly regulating key target genes, including SREBP-1c, the master transcriptional regulator of fatty acid synthesis, and fatty acid synthase (FAS), a key enzyme in the de novo biosynthesis of fatty acids. 24 -26 The present study measured the levels of LXRα and SREBP-1c mRNA and protein, the activity of FAS and the serum content of FFA and triglyceride (TG) in rats that had been fed a fatty diet in order for them to develop NASH. The aim of the study was to examine the potential role of LXRα-and SREBP-1cmediated lipid metabolism in the development of NASH.
Materials and methods

ANIMAL MODEL
Adult 4-week-old male Wistar rats (Experimental Animal Centre, Daping Hospital, Third Military Medical University, Chongqing, China), were housed four per cage in 12-h light/dark cycles (light on at 06.00 h) at room temperature (22°C), and allowed free access to food and water. Experimental procedures were performed in accordance with the institutional guidelines and regulations of the Institutional Animal LXRa and SREBP-1c in non-alcoholic steatohepatitis in rats Care and Use Committee at the Third Military Medical University, China in terms of satisfying the criteria for humane use of animals. At age 5 weeks, they were divided into two experimental groups, one group with 10 rats and the other group with 30. The former were fed freely with a normal diet (provided by the Experimental Animal Centre, Daping Hospital), while the latter were fed freely with a fatty diet that comprised 88% basic food, 10% lard and 2% cholesterin. The second group of rats were further equally divided into three subgroups of 10 rats which were sacrificed for blood and hepatic tissues after 9, 13 and 17 weeks. Blood samples and liver tissues were taken from the control rats at the corresponding times.
HEPATIC HISTOPATHOLOGY
The liver specimens were embedded in paraffin, cut into 4-µm sections, then deparaffinized with xylene and stained with haematoxylin and eosin. Pathological diagnosis was performed using criteria of the Nonalcoholic Steatohepatitis Clinical Research Network for the diagnosis and treatment of NASH published in Kleiner et al. 27 (constituted by the Academy of Fatty Liver and Alcoholic Liver Disease, Hepatology Branch, China Academy of Medicine).
BIOCHEMICAL ANALYSIS
Hepatic FFA and TG were measured using standard laboratory test kits (Jiancheng Bioengineering Institute, Nanjing, China). Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activity were measured in fresh serum using colorimetric assay test kits (Jiancheng Bioengineering Institute).
ANALYSIS OF MRNA USING REAL-TIME PCR
Total RNA was extracted from liver samples using TRIzol ® reagent (BioDev-Tech. Co. Ltd, Beijing, China), and SREBP-1c and LXRα mRNA were analysed using a real-time reverse transcription-polymerase chain reaction (RT-PCR) kit (Takara Biotechnology, Dalian, China) and an ABI PRISM™1 7300 Real-Time PCR system (Applied Biosystems, Foster City, CA, USA). Glyceraldehyde 3phosphate dehydrogenase (GAPDH) mRNA levels were measured as an internal control. The specific primers used for the amplification were: SREBP-1c forward 5′-AGG ATG AGG CCT ATG AC-3′, reverse 5′-CGT AGG CTT AGC TAC CGT A-3′; LXRα forward 5′-GCT CAA GCC ACA TCG G-3′, reverse 5′-GCA GCC ACC AAC TTC TCA-3′; GAPDH forward 5′-AGT TCA ACG GCA CAG TCA AG-3′, reverse 5′-TAC TCA GCA CCA GCA TCA CC-3′. The cycling programme involved preliminary denaturation at 95°C for 15 min, followed by 40 cycles of denaturation at 95°C for 30 s, annealing at 60°C for 20 s, and elongation at 75°C for 15 s, followed by a final elongation step at 75°C for 10 min. The PCR products were separated on 2% agarose gels, visualized using ethidium bromide staining and ultraviolet light, and were assessed semiquantitatively by measurement of the integrated optical density relative to the internal glyceraldehyde 3-phosphate dehydrogenase control.
WESTERN BLOT ANALYSIS
At each time point, 100 mg of hepatic tissues were harvested and homogenized with radioimmunoprecipitation lysis buffer (50 mmol/l Tris-HCl, pH 7.4, 150 mmol/l saline, 1 mmol/l phenylmethanesulphonyl fluoride, 1 mmol/l ethylenediaminetetra-acetic acid [EDTA], 5 µg/ml aprotinin, 5 µg/ml leupeptin, 1% Triton X-100, 1% sodium deoxycholate and 0.1% sodium dodecyl sulphate), followed by schizolysis for 60 min LXRa and SREBP-1c in non-alcoholic steatohepatitis in rats at 4°C. Lysates were then centrifuged at 26 000 g for 15 min and the supernatant was collected and measured. Equal amounts of protein extract (50 µg) were separated by 12% sodium dodecyl sulphatepolyacrylamide gel electro phoresis (SDS-PAGE) and transferred to a nitrocellulose membrane using a Trans-Blot ® Semi-Dry Electrophoretic Transfer Cell (Bio-Rad Laboratories, Hercules, CA, USA). The membrane was blocked with Tris-buffered saline solution (TBS; 20 mmol/l Tris-HCl, 150 mmol/l saline and 0.1% Tween-20) containing 5% non-fat dry milk for 1 h and incubated with goat LXRα (1 : 600 dilution) and rabbit SREBP-1c (1 : 400 dilution) primary antibodies (Santa Cruz, Biotechnology, Santa Cruz, CA) overnight at 4°C. The membranes were washed three times with 1 × TBS (Zhongshan Golden Bridge Biotechnology, Beijing, China) before being incubated with peroxidase conjugated antigoat (1 : 3000 dilution) and antirabbit (1 : 4000 dilution) secondary antibodies (Zhongshan Golden Bridge Biotechnology) for 1 h at room temperature. The membranes were washed three times with 1 × phosphate-buffered saline, pH 7.4 (Zhongshan Golden Bridge Biotechnology) and the antigen-antibody complexes were detected by enhanced chemiluminescence (Amersham ECL™ system; GE Healthcare Biosciences, Piscataway, NJ, USA). The Western blot bands were quantified by scanning densitometry using Scion Image Software (Becton Dickinson Medical Devices Co. Ltd, Suzhou, China) and levels of LXRα and SREBP-1c protein were assessed semiquantitatively by measurement of the IOD relative to the internal protein control (β-actin).
HEPATIC FAS ACTIVITY ASSAY
Purification of FAS from rat liver was carried out using a previously described method 28 and used PAGE in the presence and absence of SDS. FAS protein was stored in 0.1 M potassium phosphate buffer, pH 7.0, containing 10 mmol/l dithiothreitol (DTT) and 1 mmol/l EDTA. During all subsequent experiments, 1 mmol/l DTT and 1 mmol/l EDTA were added to the reaction solutions to protect the essential thiol groups of FAS and to remove metal ions which could inactivate FAS. The activity of FAS was determined with a Beckman DU7500 spectrophotometer (Beckman Coulter, Brea, CA, USA) at 37°C by following the decrease in the reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) at 340 nm, as described previously. 29 The reaction mixture contained 100 mmol/l potassium phosphate buffer pH 7.0, 1 mmol/l EDTA, 1 mmol/l DTT, 6 µmol/l acetyl coenzyme A, 12 µmol/l malonyl coenzyme A, 37.5 µmol/l NADPH and 20 µg rat liver FAS in a total volume of 2.0 ml.
STATISTICAL ANALYSES
The mean ± SE of the data were calculated and statistical analyses were carried out using the SPSS ® statistical package, version 13.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . The effects of various treatments were compared by one-way analysis of variance. A P-value < 0.05 was regarded as statistically significant.
Results
HEPATIC HISTOPATHOLOGY
In contrast to controls (Fig. 1A) , over the course of the study, the livers of the rats fed with a high-fat diet developed NASH and demonstrated steatosis, ballooning and lobular inflammation; predominantly initially in zone 3 of the acinus, with gradual spread into the pericentral region but with relative sparing of portal areas; lobular inflammation in NASH was typically quite LXRa and SREBP-1c in non-alcoholic steatohepatitis in rats mild (Figs 1B -1D ). At 9 weeks, in rats fed a high-fat diet, hepatocellular steatosis was < 5% in zone 3, with no ballooning or lobular inflammation (identified as F 0 G 0 ; Fig.  1B) . At 13 weeks, in rats fed a high-fat diet, hepatocellular steatosis had reached 33%, with a little ballooning in zone 3 and there was still no lobular inflammation (identified as F 2 G 1 ; Fig. 1C ). At 17 weeks, in rats fed a high-fat diet, hepatocellular steatosis was 67%, with massive ballooning, as well as lobular inflammation in the perisinusoidal regions of zone 3 (identified as F 3 G 3 ; Fig. 1D ).
BIOCHEMICAL ANALYSES
Hepatic FFA and TG levels at 9, 13 and 17 weeks, were all significantly higher in the rats with NASH than in controls (P < 0.05 or P < 0.01; Figs 2A, 2B). Compared with controls, rats with NASH had significantly elevated AST and ALT levels at 13 and 17 weeks (both P < 0.01), but not at 9 weeks (Figs 2C, 2D ).
LXRa AND SREBP-1C MRNA AND PROTEIN LEVELS
Levels of LXRα mRNA (Fig. 3A) and SREBP-1c mRNA (Fig. 3B ) at 9, 13 and 17 weeks in the livers of rats fed a high-fat diet increased with time. At 9 weeks, levels of LXRα and SREBP-1c mRNA in the NASH rats were significantly greater than in the control rats Fig. 4) , reflecting the increases observed in mRNA.
HEPATIC FAS ACTIVITY ASSAY
Hepatic FAS activity increased with time and was significantly increased at all time points (9, 13 and 17 weeks) compared with the control (P < 0.01; Fig. 5 ).
Discussion
Steatosis, fibrosis and necroinflammation characterize NASH, which is a disease that may eventually develop into cirrhosis and hepatocellular carcinoma. It is highly prevalent among obese individuals and among patients with diabetes mellitus type 2. 30, 31 The precursor to NASH is NAFLD, which is the main cause of elevated serum liver enzymes among the general In NASH, the liver is programmed to lipogenesis rather than to glycogenesis, hence the major role played by lipid metabolism in NASH. 32, 33 The master transcription factor that regulates the expression of a number of metabolic genes involved in the partitioning of nutrients into lipid storage is SREBP-1c. 12, 34 It enhances the expression of multiple lipogenic genes, such as the gene that encodes FAS, 35 and its expression is regulated by a heterodimer of nuclear receptor-type transcription factors, of which LXRα has been reported to regulate lipid metabolism in liver and adipose tissue. 36, 37 Specific LXR knockouts have revealed that LXRα is essential for the response to a dietary cholesterol overload. 38 The present study showed that serum lipid profiles increased in rats fed a high cholesterol and high-fat diet. FFA and TG levels at 9, 13 and 17 weeks were significantly higher in rats that developed NASH than in controls. Additionally, LXRα and SREBP-1c mRNA and protein levels in the rat livers were also increased following exposure to a high-fat diet. The physiological ligands for LXR are oxysterols that are derived from dietary lifestyle factors and effects on cholesterol metabolic pathways. 39 We suggest that overexpression of the LXRa gene simultaneously upregulated the SREBP-1c gene in response to an overload in sterol oxidation. The mechanism of this may be that LXRα forms heterodimers with retinoid X receptors (RXR) to regulate expression of the SREBP-1c gene in the liver. 40, 41 The RXR/LXRα complex is recruited to the SREBP-1c promoter and activates SREBP-1c transcription. 42, 43 The activity of hepatic FAS was found to be increased in parallel with an increase in LXRα and SREBP-1c mRNA and protein levels, suggesting that RXR/LXRα increases endogenous SREBP-1c gene expression, thereby upregulating FAS. SREBP-1c is synthesized as a precursor protein that remains bound to the endoplasmic reticulum and the nuclear envelope in the presence of sufficient sterol concentrations. Upon sterol deprivation, the precursor protein undergoes a sequential two-step cleavage process to release the NH 2 -terminal portion. 44 The mature SREBP-1c then enters the nucleus and activates the transcription of genes involved in fatty acid synthesis by binding to a sterol SREBP-1c 68 kDa LXRa and SREBP-1c in non-alcoholic steatohepatitis in rats regulatory element (SRE) or to palindromic sequences (E boxes), within promoter regions of target genes, to activate them. 45, 46 In addition, there is an LXR element (LXRE) in the FAS promoter and RXR/LXRα may also directly affect FAS gene expression. 47 The present study showed that hepatic FFA and TG levels were increased accordingly. These data suggest that, when FFA and TG increased to a level that was beyond the limit of self-adjustment and adaptability, excessive TG accumulated in the hepatocytes. In addition, excessive FFA was transformed into TG and accumulated in the cells. The observation of the hepatic histopathology in rats with NASH also showed that hepatocellular steatosis occurred in parallel to elevation of FFA and TG. Having eaten the high-fat diet for 13 weeks, rat livers showed a little ballooning in zone 3 of the acinus. By 17 weeks of the high-fat diet, massive ballooning could be seen, as well as lobular inflammation in the perisinusoidal regions of zone 3 of the rat livers. Meanwhile, serum AST and ALT levels were elevated at 13 and 17 weeks. These phenomena indicate that FFA and TG over-accumulation induced the progression to steatohepatitis and the infiltration of inflammatory cells. FFA and TG over-accumulation renders the liver more susceptible to 'second hits'; i.e. once they had imposed upon the steatotic liver, this caused further aberrations that culminated in the development of NASH. Previous reports have demonstrated that fatty acids, such as TG and FFA, may represent an intrinsic 'second hit' to the liver that hastens the development of NASH. 32 As FFA is an amphipathic molecule, excessive FFA in the cell might induce cytotoxicity either directly or through sensitization to other agents. 48 Metabolic dysregulation, mitochondrial impairment and oxidative stress have significant roles in determining hepatocyte damage and result in profound changes in gene expression leading, ultimately, to apoptosis and contributing to the inflammatory process. 49 Thus, the increased flow of FFAs to the liver in NASH is considered to be one of the most important factors contributing to more serious disease.
In conclusion, a difference in LXRa and SREBP-1c gene expression was found between rats with NASH and control animals suggesting that, in the development of NASH, over-expression of LXRa is induced by a high cholesterol and high-fat diet. Overexpression of LXRa seems to prompt overexpression of SREBP-1c which, in turn, could upregulate hepatic FAS activity. It seems that, when the synthesis of FFA exceeds the mechanisms to metabolize it, excessive TG accumulates in the hepatocytes, to steatosis and the inflammatory process and, eventually, resulting in NASH. These findings provide evidence that LXRα and SREBP-1c play important roles in the development of NASH mediated by lipid disorder.
